GENEVA--(BUSINESS WIRE)-- Regulatory News: Alcon (SIX/NYSE: ALC), the global leader in eye care dedicated to helping people see brilliantly, today announced its intention to acquire Ivantis®, ...

Ivantis Inc., the maker of one of the smallest medical devices in the world, is getting acquired at a big price. Alcon Inc., the world’s largest eye care device company, announced Nov. 8 it plans to ...

IRVINE, CA--(Marketwired - Apr 25, 2017) - Ivantis Inc., developer of the novel Hydrus™ Microstent device, designed to lower eye pressure for glaucoma patients, announced today that the US Food and ...

IRVINE, CA--(Marketwired - Jan 9, 2017) - Ivantis Inc., developer of the novel Hydrus™ Microstent device designed to lower eye pressure for glaucoma patients, announced today that it closed a $25 ...

(RTTNews) - Alcon (ALC), an American-Swiss medical company specializing in eye care products, said on Monday it will acquire Ivantis Inc., a developer and manufacturer of the novel Hydrus Microstent, ...

Alcon AG reported its plans to acquire Ivantis Inc., adding the Hydrus microstent for glaucoma to its ophthalmology portfolio. Ivantis will receive $475 million at closing, with additional unspecified ...

Please provide your email address to receive an email when new articles are posted on . Glaukos Corporation filed a patent infringement lawsuit against Ivantis Inc., according to a company press ...

Irvine medical device maker Ivantis Inc. said Monday that it has received $17 million in a second round of venture funding. Ivantis plans to use the money to expand clinical activities for its Hydrus ...

Sight Sciences Inc. may have visions of a substantial settlement following Ivantis Inc.’s $60 million settlement with Glaukos Corp. this week or the Menlo Park, Calif.-based company may have its ...

Please provide your email address to receive an email when new articles are posted on . Glaukos and Ivantis have entered into a settlement agreement to terminate a patent infringement lawsuit ...

Ivantis Inc. is a privately-held company established in 2007 to design, develop and commercialize new technologies to treat eye disease. Investors include New Enterprise Associates, Delphi Ventures, ...